Barnes Wendy Lynn

See Remarks, DirectorGoodRx Holdings, Inc. (GDRX) · full profile →Form 4 · filed Apr 15, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)115K543K
Apr 15, 2026Tax withholding(F)50K$2.23$112K493K
Apr 15, 2026Option exercise(M)51K544K
Apr 15, 2026Tax withholding(F)22K$2.23$50K522K
Apr 15, 2026Option exercise(M)111K633K
Apr 15, 2026Tax withholding(F)48K$2.23$107K585K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)115K$01.3M
Apr 15, 2026Option exercise(M)51K$0154K
Apr 15, 2026Option exercise(M)111K$01.2M

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001809519-26-000074) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about GDRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001809519-26-000074"
Ask your agent
Use Arkolith to summarize insider buying and selling at GoodRx Holdings, Inc.
over the last 90 days and cite the filings.